Advanced Viral Research Corp. announces receipt of preliminary report of optimistic results in treatment of HPV.HALLANDALE, Fla.--(BUSINESS WIRE)--July 25, 1996--Advanced Viral Research Corp. (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). BB:ADVR ADVR Association of Directors of Volunteer Resources (Canada) ) of Hallandale is pleased to announce the receipt of a letter with preliminary results of the open label human papilloma virus human papilloma virus n. Abbr. HPV A DNA virus of the genus Papillomavirus, certain types of which cause cutaneous and genital warts in humans, including condyloma acuminatum. (genital warts genital warts: see human papillomavirus. ) trial in Argentina conducted by Dr. Juan Carlos Flichman. The letter states that reticulose is completely safe to use in "topic application." Referring to the efficacy on mucous genital lesions in the uterus in 10 women selected, Dr. Flichman stated, "I can inform you that I am optimistic with the results obtained." Dr. Flichman expects to deliver the scientific work with the final results at the end of August. He expects to present these results at an international meeting some time in September or October. Dr. Juan Carlos Flichman is president of The Union of Argentina Against Sexually Transmitted Diseases Sexually transmitted diseases Infections that are acquired and transmitted by sexual contact. Although virtually any infection may be transmitted during intimate contact, the term sexually transmitted disease is restricted to conditions that are largely (UACETS) and president of Union of Latin America Against Sexually Transmitted Diseases (ULACETS). Dr. Flichman was a charter member of The Argentina Ministry of Health in Control of the Sexually Transmitted Diseases and AIDS. Reticulose is a non-toxic antiviral peptide nucleic acid preparation by Advanced Viral Research Corp. which, based on previous history, has been shown to be effective against a number of viral diseases. For information, contact William Bregman at 954/458-7636. CONTACT: Advanced Viral Research Corp., Hallandale William Bregman, 954/458-7636 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion